Vibration and β-hydroxy-β-methylbutyrate treatment suppresses intramuscular fat infiltration and adipogenic differentiation in sarcopenic mice

Jinyu Wang, Can Cui, Yu Ning Chim, Hao Yao, Liu Shi, Jiankun Xu, Jiali Wang, Ronald Man Yeung Wong, Kwok-Sui Leung, Simon Kwoon-Ho Chow, Wing Hoi Cheung, Jinyu Wang, Can Cui, Yu Ning Chim, Hao Yao, Liu Shi, Jiankun Xu, Jiali Wang, Ronald Man Yeung Wong, Kwok-Sui Leung, Simon Kwoon-Ho Chow, Wing Hoi Cheung

Abstract

Background: Sarcopenia is an aging-induced deterioration of skeletal muscle mass and function. Low-magnitude high-frequency vibration (LMHFV) was shown to improve muscle functions and β-hydroxy-β-methylbutyrate (HMB) to increase muscle mass and strength. Muscle-derived stem cells (MDSCs) are progenitor cells important for muscle regeneration. We hypothesized that LMHFV and HMB could retard sarcopenia by reducing fat infiltration through inhibiting adipogenesis in MDSCs.

Methods: Senescence-accelerated mouse P8 male mice were randomized into control (CTL), HMB, LMHFV (VIB), and combined (COM) groups. Interventions started at age of month 7 and assessed at 1, 2, and 3 months post-intervention by densitometry, histology, and functional tests. In vitro, MDSCs isolated from gastrocnemius of senescence-accelerated mouse P8 mice were characterized, randomized into CTL, VIB, HMB, and COM groups, and assessed by oil red O staining, mRNA, and protein expression.

Results: At 2 months post-intervention, percentage lean mass of HMB, VIB, and COM groups were significantly higher than CTL group. Twitch, tetanic, and specific tetanic forces of COM group were higher, while specific twitch force of both VIB and COM groups were higher. Grip strength of HMB, VIB, and COM groups were higher. Histologically, both VIB and COM groups presented lower oil red O area than CTL group. Type I muscle fibre in CTL group was higher than HMB, VIB, and COM groups. MDSC were detected in situ by immunofluorescence stain with stem cell antigen-1 signals confirmed with higher β-catenin expression in the COM group. The observations were also confirmed in vitro, MDSCs in the HMB, VIB, and COM groups presented lower adipogenesis vs. the CTL group. β-Catenin mRNA and protein expressions were lower in the CTL group while their relationship was further validated through β-catenin knock-down approach.

Conclusions: Our results showed that combined LMHFV and HMB interventions enhanced muscle strength and decreased percentage fat mass and intramuscular fat infiltration as compared with either treatment alone. Additive effect of LMHFV and HMB was demonstrated in β-catenin expression than either treatment in MDSCs and altered cell fate from adipogenesis to myogenesis, leading to inhibition of intramuscular lipid accumulation. Wnt/β-catenin signalling pathway was found to be the predominant regulatory mechanism through which LMHFV and HMB combined treatment suppressed MDSCs adipogenesis.

Keywords: Fat infiltration; HMB; LMHFV; MDSC; Sarcopenia; Wnt/β-catenin.

Conflict of interest statement

The authors declare no conflict of interest and certify that they comply with the ethical guidelines for authorship and publishing of the Journal of Cachexia, Sarcopenia, and Muscle.51

© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Figures

Figure 1
Figure 1
Body composition evaluation of SAMP8 mice by dual energy X‐ray absorptiometry (DXA). (A) Percentage lean mass and (B) percentage fat mass of SAMP8 mice in different groups at 1, 2, and 3 months. Percentage lean mass in CTL group was lower than HMB, VIB, and COM groups at month 2 post‐intervention, while the percentage fat mass in CTL group was higher than HMB, VIB, and COM groups at month 2. (C) Representative image of whole‐body DXA scanning (lean mass mode) (D) and (fat mass mode) demonstrating that the HMB, VIB, and COM groups showed higher percentage lean mass and lower fat mass at month 2, respectively. Lean and fat masses indicated by white arrows. *P < 0.05; **P < 0.01. (E) Serum myostatin level of COM group showed significantly higher than CTL group at month 3. (F) Serum adiponectin level of VIB group showed significantly higher than CTL group at month 3. *P < 0.05. HMB, β‐hydroxy‐β‐methylbutyrate; SAM, senescence‐accelerated mouse.
Figure 2
Figure 2
Morphological differences and fat infiltration of skeletal muscles in senescence‐accelerated mouse P8 mice upon different treatments. (A) H&E, oil red O (ORO), and myosin heavy chain (MHC) staining of muscle histology in different groups at month 3. CTL group presented more intramuscular fat tissue than HMB, VIB, and COM groups at month 3 by H&E where fat tissues are indicated by yellow arrows. HMB, VIB, and COM groups presented lower ORO signal (red area) than the CTL group at month 3. At the gastrocnemius, percentage area of type I fibre (blue) in the CTL group was significantly higher than all treatment groups with no significant difference detected in type IIa and IIb fibres at month 3. (B) CTL group showed higher percentage type I fibres than HMB, VIB, and COM groups by MHC immunofluorescence staining at month 3 (***P < 0.001). (C) Quantitative analysis revealed that ORO area of both VIB and COM groups was significantly higher than CTL group at month 3, *P < 0.05, **P < 0.01. HMB, β‐hydroxy‐β‐methylbutyrate.
Figure 3
Figure 3
In situ detection of muscle‐derived stem cells (MDSC) and β‐catenin expression. (A) MDSC was detected and identified by positive stem cell antigen‐1 (Sca‐1, green) signal, highlighted against basal lamina surrounded muscle fibres (laminin, red) with nuclei stained with DAPI (blue). All MDSC were observed to reside between muscle fibres scattered across the muscle section (white arrows). (B) Western blot analysis showed that total β‐catenin content were increased in the treatment groups compared with the CTL group after 3 months of treatment with only the combine treatment (COM) group reaching statistical significant difference (* n = 3, P < 0.05, analysis of variance with Bonferroni post hoc test).
Figure 4
Figure 4
Muscle strength of senescence‐accelerated mouse P8 mice upon different treatments at various time points. (A) Twitch force (F0) of COM group was significantly higher than CTL group at month 3 post‐intervention. No significant difference was found in other groups. (B) Tetanic force (Ft) of COM group was significantly higher than CTL group at month 3 with no significant difference detected in other groups. (C) Specific twitch force (SF0) of VIB and COM groups were significantly higher than CTL group at month 3 with no significant difference detected in other groups. (D) Specific tetanic force (SFt) of COM group was significantly higher than CTL group at month 3 with no significant difference detected in other groups. (E) The grip strength of HMB, VIB, and COM groups were significantly higher than CTL group at month 3. *P < 0.05; **P < 0.01; ***P < 0.001. HMB, β‐hydroxy‐β‐methylbutyrate.
Figure 5
Figure 5
Morphology and characterization of muscle‐derived stem cells (MDSC) at different stages of their isolation utilizing the pre‐plate technique. (A) PP1 cells isolated from muscle of SAMP8 mice. (B) PP3 cells from muscle of SAMP8 mice. (C) PP6 MDSCs isolated from muscle of SAMP8 mice. MDSCs are indicated by yellow arrows. (D) Alizarin red S staining at day 10 after osteogenic induced culture in MDSCs. (E) Oil red O staining at day 10 after adipogenic induced culture in MDSCs. (F) Immunofluorescence staining of MDSCs at day 5 after myogenic induction. Myotubes are indicated by white arrows, green area is myosin heavy chain IIa positive, and the blue area is nucleus stained by DAPI. SAM, senescence‐accelerated mouse.
Figure 6
Figure 6
ORO staining of MDSCs after adipogenic induction upon different treatments. (A) CTL group showed more adipogenic cells than HMB, VIB, and COM groups. (B) Quantitative data showed that all treatment groups presented significantly less ORO positive area than the CTL group. The COM group showed significantly less adipogenic cells than HMB group. (C) PPARγ mRNA expression level in CTL group was significantly higher than HMB, VIB, and COM groups. (D) PGC1α mRNA expression in CTL group was significantly higher than VIB and COM groups. PGC1α mRNA expression in COM group was significantly lower than HMB group. (E) C/EBPα mRNA expression in CTL group was significantly higher than COM group and marginally higher than HMB group. (F) Relative expression of β‐catenin mRNA in CTL group was significantly lower than HMB and COM groups. (G) Western blot results revealed that HMB, VIB, and COM groups had significantly higher β‐catenin protein level than CTL group. *P < 0.05; **P < 0.01; ***P < 0.001. HMB, β‐hydroxy‐β‐methylbutyrate; ORO, oil red O.
Figure 7
Figure 7
Treatment effects on adipogenesis differentiation in MDSC abolished by si‐β‐catenin knockdown. (A) CTL group showed more adipogenic cells than HMB, VIB, and COM groups after si‐NC knockdown, while no obvious difference was seen among groups after si‐β‐catenin knockdown. (B) Quantitative data showed that VIB and COM groups presented significantly less ORO area than CTL group after si‐NC knockdown, while no significant difference was seen among groups after si‐β‐catenin knockdown. (C) PPARγ mRNA expression in CTL group was significantly higher than COM group after si‐NC knockdown, while no significant difference was seen among groups after si‐β‐catenin knockdown. PGC1α mRNA expression in CTL group was significantly higher than COM group after si‐NC knockdown. No significant difference was seen among groups after si‐β‐catenin knockdown. C/EBPα mRNA expression in CTL group was significantly higher than COM group after si‐NC knockdown. No significant difference of C/EBPα mRNA was seen among groups after si‐β‐catenin knockdown. (F) Relative expression of β‐catenin mRNA in CTL group was significantly lower than HMB, VIB, and COM groups after si‐NC knockdown, but no significant difference was seen among groups after si‐β‐catenin knockdown. (G) Western blot result revealed that no significant difference of β‐catenin protein level was seen among groups after si‐β‐catenin knockdown, while HMB, VIB, and COM groups had significantly higher β‐catenin protein level than CTL group after si‐NC knockdown. *P < 0.05; **P < 0.01. HMB, β‐hydroxy‐β‐methylbutyrate; MDSC, muscle‐derived stem cell; ORO, oil red O.

References

    1. Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–423.
    1. Cruz‐Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014;43:748–759.
    1. Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age‐related skeletal muscle wasting and weakness. Biogerontology 2008;9:213–228.
    1. Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, et al. Prevalence and clinical correlates of sarcopenia in community‐dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2014;69:438–446.
    1. von Stengel S, Kemmler W, Engelke K, Kalender WA. Effects of whole body vibration on bone mineral density and falls: results of the randomized controlled ELVIS study with postmenopausal women. Osteoporos Int 2011;22:317–325.
    1. Goudarzian M, Ghavi S, Shariat A, Shirvani H, Rahimi M. Effects of whole body vibration training and mental training on mobility, neuromuscular performance, and muscle strength in older men. J Exerc Rehabil 2017;13:573–580.
    1. Leung KS, Li CY, Tse YK, Choy TK, Leung PC, Hung VW, et al. Effects of 18‐month low‐magnitude high‐frequency vibration on fall rate and fracture risks in 710 community elderly—a cluster‐randomized controlled trial. Osteoporos Int 2014;25:1785–1795.
    1. Guo AY, Leung KS, Qin JH, Chow SK, Cheung WH. Effect of low‐magnitude, high‐frequency vibration treatment on retardation of sarcopenia: senescence‐accelerated mouse‐P8 model. Rejuvenation Res 2016;19:293–302.
    1. Hamrick MW, McGee‐Lawrence ME, Frechette DM. Fatty infiltration of skeletal muscle: mechanisms and comparisons with bone marrow adiposity. Front Endocri (Lausanne) 2016;7:69.
    1. Nissen SL, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta‐analysis. J Appl Physiol (1985) 2003;94:651–659.
    1. Jowko E, Ostaszewski P, Jank M, Sacharuk J, Zieniewicz A, Wilczak J, et al. Creatine and beta‐hydroxy‐beta‐methylbutyrate (HMB) additively increase lean body mass and muscle strength during a weight‐training program. Nutrition 2001;17:558–566.
    1. Panton LB, Rathmacher JA, Baier S, Nissen S. Nutritional supplementation of the leucine metabolite beta‐hydroxy‐beta‐methylbutyrate (HMB) during resistance training. Nutrition 2000;16:734–739.
    1. Durkalec‐Michalski K, Jeszka J. The effect of beta‐hydroxy‐beta‐methylbutyrate on aerobic capacity and body composition in trained athletes. J Strength Cond Res 2016;30:2617–2626.
    1. Young HE, Ceballos EM, Smith JC, Mancini ML, Wright RP, Ragan BL, et al. Pluripotent mesenchymal stem cells reside within avian connective tissue matrices. In Vitro Cell Dev Biol Anim 1993;29A:723–736.
    1. Lough D, Swanson E, Sopko NA, Madsen C, Miller D, Wang H, et al. Regeneration of vascularized corticocancellous bone and diploic space using muscle‐derived stem cells: a translational biologic alternative for healing critical bone defects. Plast Reconstr Surg 2017;139:893–905.
    1. Deasy BM, Feduska JM, Payne TR, Li Y, Ambrosio F, Huard J. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther 2009;17:1788–1798.
    1. Guo AY, Leung KS, Siu PM, Qin JH, Chow SK, Qin L, et al. Muscle mass, structural and functional investigations of senescence‐accelerated mouse P8 (SAMP8). Exp Animals/Japanese Assoc Lab Animal Sci 2015;64:425–433.
    1. Kovarik M, Muthny T, Sispera L, Holecek M. Effects of beta‐hydroxy‐beta‐methylbutyrate treatment in different types of skeletal muscle of intact and septic rats. J Physiol Biochem 2010;66:311–319.
    1. Kim JS, Park YM, Lee SR, Masad IS, Khamoui AV, Jo E, et al. Beta‐hydroxy‐beta‐methylbutyrate did not enhance high intensity resistance training‐induced improvements in myofiber dimensions and myogenic capacity in aged female rats. Mol Cells 2012;34:439–448.
    1. Park BS, Henning PC, Grant SC, Lee WJ, Lee SR, Arjmandi BH, et al. HMB attenuates muscle loss during sustained energy deficit induced by calorie restriction and endurance exercise. Metab Clinic Exper 2013;62:1718–1729.
    1. Zhang N, Chow SKH, Leung KS, Lee HH, Cheung WH. An animal model of co‐existing sarcopenia and osteoporotic fracture in senescence accelerated mouse prone 8 (SAMP8). Exp Gerontol 2017;97:1–8.
    1. Del Prete Z, Musaro A, Rizzuto E. Measuring mechanical properties, including isotonic fatigue, of fast and slow MLC/mIgf‐1 transgenic skeletal muscle. Ann Biomed Eng 2008;36:1281–1290.
    1. Bloemberg D, Quadrilatero J. Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS ONE 2012;7:e35273.
    1. Yu CO, Leung KS, Jiang JL, Wang TB, Chow SK, Cheung WH. Low‐magnitude high‐frequency vibration accelerated the foot wound healing of n5‐streptozotocin‐induced diabetic rats by enhancing glucose transporter 4 and blood microcirculation. Sci Rep 2017;7:11631.
    1. Gharaibeh B, Lu A, Tebbets J, Zheng B, Feduska J, Crisan M, et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 2008;3:1501–1509.
    1. Wei FY, Leung KS, Li G, Qin J, Chow SK, Huang S, et al. Low intensity pulsed ultrasound enhanced mesenchymal stem cell recruitment through stromal derived factor‐1 signaling in fracture healing. PLoS ONE 2014;9:e106722.
    1. Fung CH, Cheung WH, Pounder NM, Harrison A, Leung KS. Osteocytes exposed to far field of therapeutic ultrasound promotes osteogenic cellular activities in pre‐osteoblasts through soluble factors. Ultrasonics 2014;54:1358–1365.
    1. Chung SL, Leung KS, Cheung WH. Low‐magnitude high‐frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. J Orthop Res 2014;32:1572–1579.
    1. Wilson JM, Lowery RP, Joy JM, Andersen JC, Wilson SM, Stout JR, et al. The effects of 12 weeks of beta‐hydroxy‐beta‐methylbutyrate free acid supplementation on muscle mass, strength, and power in resistance‐trained individuals: a randomized, double‐blind, placebo‐controlled study. Eur J Appl Physiol 2014;114:1217–1227.
    1. Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, McLeod K. Prevention of postmenopausal bone loss by a low‐magnitude, high‐frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety. J Bone Miner Res 2004;19:343–351.
    1. Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK. Age changes in body composition revealed by computed tomography. J Gerontol 1983;38:673–677.
    1. Roubenoff R, Hughes VA. Sarcopenia: current concepts. J Gerontol A Biol Sci Med Sci 2000;55:M716–M724.
    1. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well‐functioning older persons. J Gerontol A Biol Sci Med Sci 2005;60:324–333.
    1. Hirschfeld HP, Kinsella R, Duque G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 2017;28:2781–2790.
    1. Stout JR, Fukuda DH, Kendall KL, Smith‐Ryan AE, Moon JR, Hoffman JR. Beta‐hydroxy‐beta‐methylbutyrate (HMB) supplementation and resistance exercise significantly reduce abdominal adiposity in healthy elderly men. Exp Gerontol 2015;64:33–34.
    1. Verschueren SM, Bogaerts A, Delecluse C, Claessens AL, Haentjens P, Vanderschueren D, et al. The effects of whole‐body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6‐month randomized, controlled trial. J Bone Miner Res 2011;26:42–49.
    1. Wei N, Pang MY, Ng SS, Ng GY. Optimal frequency/time combination of whole body vibration training for developing physical performance of people with sarcopenia: a randomized controlled trial. Clin Rehabil 2017;31:1313–1321.
    1. Wei N, Pang MY, Ng SS, Ng GY. Optimal frequency/time combination of whole‐body vibration training for improving muscle size and strength of people with age‐related muscle loss (sarcopenia): a randomized controlled trial. Geriatr Gerontol Int 2017;17:1412–1420.
    1. Chang SF, Lin PC, Yang RS, Yang RJ. The preliminary effect of whole‐body vibration intervention on improving the skeletal muscle mass index, physical fitness, and quality of life among older people with sarcopenia. BMC Geriatr 2018;18:17.
    1. Omatsu‐Kanbe M, Matsuura H. Novel intracellular mediator of adiponectin secretion from adipocytes. J Physiol 2014;592:5141.
    1. Can B, Kara O, Kizilarslanoglu MC, Arik G, Aycicek GS, Sumer F, et al. Serum markers of inflammation and oxidative stress in sarcopenia. Aging Clin Exp Res 2017;29:745–752.
    1. Frechette DM, Krishnamoorthy D, Adler BJ, Chan ME, Rubin CT. Diminished satellite cells and elevated adipogenic gene expression in muscle as caused by ovariectomy are averted by low‐magnitude mechanical signals. J Appl Physiol (1985) 2015;119:27–36.
    1. Reijne AC, Ciapaite J, van Dijk TH, Havinga R, van der Zee EA, Groen AK, et al. Whole‐body vibration partially reverses aging‐induced increases in visceral adiposity and hepatic lipid storage in mice. PLoS ONE 2016;11:e0149419.
    1. Nissen S, Sharp R, Ray M, Rathmacher JA, Rice D, Fuller JC Jr, et al. Effect of leucine metabolite beta‐hydroxy‐beta‐methylbutyrate on muscle metabolism during resistance‐exercise training. J Appl Physiol (1985) 1996;81:2095–2104.
    1. O'Connor DM, Crowe MJ. Effects of six weeks of beta‐hydroxy‐beta‐methylbutyrate (HMB) and HMB/creatine supplementation on strength, power, and anthropometry of highly trained athletes. J Strength Cond Res 2007;21:419–423.
    1. Rossi AP, D'Introno A, Rubele S, Caliari C, Gattazzo S, Zoico E, et al. The potential of beta‐hydroxy‐beta‐methylbutyrate as a new strategy for the management of sarcopenia and sarcopenic obesity. Drugs Aging 2017;34:833–840.
    1. Luu YK, Capilla E, Rosen CJ, Gilsanz V, Pessin JE, Judex S, et al. Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary‐induced obesity. J Bone Miner Res 2009;24:50–61.
    1. Liu J, Farmer SR. Regulating the balance between peroxisome proliferator‐activated receptor gamma and beta‐catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation‐defective mutant of beta‐catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 2004;279:45020–45027.
    1. Kennell JA, MacDougald OA. Wnt signaling inhibits adipogenesis through beta‐catenin‐dependent and ‐independent mechanisms. J Biol Chem 2005;280:24004–24010.
    1. Akimoto T, Ushida T, Miyaki S, Akaogi H, Tsuchiya K, Yan Z, et al. Mechanical stretch inhibits myoblast‐to‐adipocyte differentiation through Wnt signaling. Biochem Biophys Res Commun 2005;329:381–385.
    1. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019. J Cachexia Sarcopenia Muscle 2019; 10: 1143–1145.

Source: PubMed

3
Tilaa